These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 9416841
1. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice. Curtis DJ, Robb L, Strasser A, Begley CG. Oncogene; 1997 Dec 11; 15(24):2975-83. PubMed ID: 9416841 [Abstract] [Full Text] [Related]
2. scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice. Robb L, Rasko JE, Bath ML, Strasser A, Begley CG. Oncogene; 1995 Jan 05; 10(1):205-9. PubMed ID: 7824274 [Abstract] [Full Text] [Related]
3. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Blyth K, Terry A, O'Hara M, Baxter EW, Campbell M, Stewart M, Donehower LA, Onions DE, Neil JC, Cameron ER. Oncogene; 1995 May 04; 10(9):1717-23. PubMed ID: 7753548 [Abstract] [Full Text] [Related]
4. scid Thymocytes with TCRbeta gene rearrangements are targets for the oncogenic effect of SCL and LMO1 transgenes. Chervinsky DS, Lam DH, Melman MP, Gross KW, Aplan PD. Cancer Res; 2001 Sep 01; 61(17):6382-7. PubMed ID: 11522630 [Abstract] [Full Text] [Related]
5. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Elson A, Deng C, Campos-Torres J, Donehower LA, Leder P. Oncogene; 1995 Jul 06; 11(1):181-90. PubMed ID: 7624126 [Abstract] [Full Text] [Related]
8. Selection for loss of p53 function in T-cell lymphomagenesis is alleviated by Moloney murine leukemia virus infection in myc transgenic mice. Baxter EW, Blyth K, Cameron ER, Neil JC. J Virol; 2001 Oct 06; 75(20):9790-8. PubMed ID: 11559812 [Abstract] [Full Text] [Related]
9. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc. Vaillant F, Blyth K, Terry A, Bell M, Cameron ER, Neil J, Stewart M. Oncogene; 1999 Nov 25; 18(50):7124-34. PubMed ID: 10597314 [Abstract] [Full Text] [Related]
10. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc. Karsunky H, Geisen C, Schmidt T, Haas K, Zevnik B, Gau E, Möröy T. Oncogene; 1999 Dec 16; 18(54):7816-24. PubMed ID: 10618723 [Abstract] [Full Text] [Related]
15. Overexpression of human O6-alkylguanine DNA alkyltransferase (AGT) prevents MNU induced lymphomas in heterozygous p53 deficient mice. Reese JS, Allay E, Gerson SL. Oncogene; 2001 Aug 30; 20(38):5258-63. PubMed ID: 11536039 [Abstract] [Full Text] [Related]
19. CD2 promoter regulated nucleophosmin-anaplastic lymphoma kinase in transgenic mice causes B lymphoid malignancy. Turner SD, Merz H, Yeung D, Alexander DR. Anticancer Res; 2006 Aug 30; 26(5A):3275-9. PubMed ID: 17094440 [Abstract] [Full Text] [Related]
20. Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras. Breuer M, Wientjens E, Verbeek S, Slebos R, Berns A. Cancer Res; 1991 Feb 01; 51(3):958-63. PubMed ID: 1988138 [Abstract] [Full Text] [Related] Page: [Next] [New Search]